Authors: Judson, I Radford, JA Harris, M Blay, JY van Hoesel, Q le Cesne, A van Oosterom, AT Clemons, MJ Kamby, C Hermans, C Whittaker, J di Paola, ED Verweij, J Nielsen, S

Citation: I. Judson et al., Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 37(7), 2001, pp. 870-877

Authors: Lee, SM Ryder, WDJ Clemons, MJ Morgenstern, GR Chang, J Scarffe, JH Radford, JA

Citation: Sm. Lee et al., Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma, BONE MAR TR, 24(3), 1999, pp. 271-277